22
Participants
Start Date
August 31, 2015
Primary Completion Date
May 31, 2018
Study Completion Date
May 31, 2018
Transdermal nicotine
Nicotine patches are currently FDA approved for smoking cessation. Nicotine has effects that have been well studied for many years. Studies have shown that nicotine by itself does not appear by itself to be cancer causing. The use of the nicotine patch is not expected to increase risk of breast cancer recurrence.
Placebo Transdermal Patch
Matching transdermal placebo patches will be used. Participants will follow the same titration schedule as the transdermal nicotine arm.
Center for Cognitive Medicine at Vanderbilt University, Nashville
Vanderbilt University Medical Center
OTHER